Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/07/3000 : 18Business WireEmpire State Building Partners with Sea Bags and Max to Transform Fabric from 270-Foot Dragon into Recycled Tote BagsNYSE:ESRTEmpire State Realty Trust Inc
2024/07/3000 : 15Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNYSE:HLGNHeliogen Inc
2024/07/3000 : 15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
2024/07/3000 : 15Business WirePropel Fuels’s Trade Secret Theft Case Against Phillips 66 Scheduled for Trial August 26, 2024
2024/07/3000 : 15PR Newswire (US)ILLY FIRST HALF 2024 RESULTS
2024/07/3000 : 15PR Newswire (US)Podcast Journalism: reVolver Podcasts Launches "Testigo Directo"
2024/07/3000 : 15PR Newswire (US)ILLY FIRST HALF 2024 RESULTS
2024/07/3000 : 15PR Newswire (US)U.S. Minority Business Development Agency and Urban Strategies, Inc. Announce New Partnership to Strengthen Opportunities and Access for Minority Businesses
2024/07/3000 : 14Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
2024/07/3000 : 12Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:TDToronto Dominion Bank
2024/07/3000 : 12Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
2024/07/3000 : 12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:PHRPhreesia Inc
2024/07/3000 : 12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
2024/07/3000 : 12PR Newswire (US)Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
2024/07/3000 : 11PR Newswire (Canada)Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
2024/07/3000 : 11PR Newswire (US)Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
2024/07/3000 : 10Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
2024/07/3000 : 10Alliance NewsAlliance NewsUK chancellor sets out plan to deal with "GBP22 billion" budget hole
2024/07/3000 : 09GlobeNewswire Inc.Porsche celebrates 25 years of automotive technical training excellence
2024/07/3000 : 08Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
2024/07/3000 : 08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
2024/07/3000 : 07PR Newswire (US)Patients in Hospitals that Provide Inpatient Addiction Services Were More Likely to Start and Continue Lifesaving Medication for Opioid Use Disorder Treatment After Discharge
2024/07/3000 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FLWS1 800 Flowers Com
2024/07/3000 : 06GlobeNewswire Inc.Federal Home Loan Bank of New York Announces $5 Million in Small Business Grant Funding
2024/07/3000 : 05Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
2024/07/3000 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:RCGRENN Fund Inc
2024/07/3000 : 04Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:JPM-MJP Morgan Chase and Co
2024/07/3000 : 04Business WireGrant Thornton names 56 new partners, principals and managing directors
2024/07/3000 : 02Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
2024/07/3000 : 02Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co